In conclusion, our investigation elucidates the pivotal role of OVOL1 in modulating the proliferation and metastasis of non‐small cell lung cancer (NSCLC) via its governance on APOE‐mediated cholesterol metabolic pathways. Here, APOE is linked to non-small cell lung carcinoma.